BioPharma Credit (BPCR) Competitors

BioPharma Credit (LON:BPCR) and abrdn (LON:ABDN) are both financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk.

Which has higher valuation and earnings, BPCR or ABDN?

BioPharma Credit has higher revenue and earnings than abrdn. BioPharma Credit is trading at a lower price-to-earnings ratio than abrdn, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioPharma Credit	£12.99B	0.08	£10.42B	£0.09	9.89
abrdn	£1.49B	2.44	£316.36M	£17.59	11.59

Do analysts rate BPCR or ABDN?

abrdn has a consensus target price of GBX 184.33, suggesting a potential downside of 9.55%. Given abrdn's stronger consensus rating and higher possible upside, analysts plainly believe abrdn is more favorable than BioPharma Credit.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioPharma Credit	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
abrdn	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Is BPCR or ABDN more profitable?

BioPharma Credit has a net margin of 80.20% compared to abrdn's net margin of 21.19%. BioPharma Credit's return on equity of 8.51% beat abrdn's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioPharma Credit	80.20%	8.51%	4.98%
abrdn	21.19%	6.46%	0.68%

Do insiders and institutionals have more ownership in BPCR or ABDN?

41.5% of BioPharma Credit shares are owned by institutional investors. Comparatively, 38.2% of abrdn shares are owned by institutional investors. 6.2% of BioPharma Credit shares are owned by company insiders. Comparatively, 2.4% of abrdn shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the media refer more to BPCR or ABDN?

In the previous week, abrdn had 2 more articles in the media than BioPharma Credit. MarketBeat recorded 2 mentions for abrdn and 0 mentions for BioPharma Credit. BioPharma Credit's average media sentiment score of 0.00 equaled abrdn'saverage media sentiment score.

Company	Overall Sentiment
BioPharma Credit	Neutral
abrdn	Neutral

Which has more volatility and risk, BPCR or ABDN?

BioPharma Credit has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500. Comparatively, abrdn has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

Is BPCR or ABDN a better dividend stock?

BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 804.6%. abrdn pays an annual dividend of GBX 15 per share and has a dividend yield of 7.4%. BioPharma Credit pays out 7,957.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. abrdn pays out 85.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

abrdn beats BioPharma Credit on 9 of the 17 factors compared between the two stocks.